These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 1684220)
21. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Janus C; Pearson J; McLaurin J; Mathews PM; Jiang Y; Schmidt SD; Chishti MA; Horne P; Heslin D; French J; Mount HT; Nixon RA; Mercken M; Bergeron C; Fraser PE; St George-Hyslop P; Westaway D Nature; 2000 Dec 21-28; 408(6815):979-82. PubMed ID: 11140685 [TBL] [Abstract][Full Text] [Related]
22. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease. Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021 [TBL] [Abstract][Full Text] [Related]
23. Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice. Zohar O; Pick CG; Cavallaro S; Chapman J; Katzav A; Milman A; Alkon DL Neurobiol Aging; 2005; 26(8):1167-75. PubMed ID: 15917100 [TBL] [Abstract][Full Text] [Related]
24. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635 [TBL] [Abstract][Full Text] [Related]
25. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798 [TBL] [Abstract][Full Text] [Related]
26. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
28. Amyloid beta protein precursor and the pathogenesis of Alzheimer's disease. Selkoe DJ Cell; 1989 Aug; 58(4):611-2. PubMed ID: 2504495 [No Abstract] [Full Text] [Related]
30. [Current state of Alzheimer's disease models: a brief overview]. Michikawa M Nihon Rinsho; 2011 Oct; 69 Suppl 8():233-40. PubMed ID: 22787788 [No Abstract] [Full Text] [Related]
31. Cholesterol and Lipid Rafts in the Biogenesis of Amyloid-β Protein and Alzheimer's Disease. Pantelopulos GA; Abraham CB; Straub JE Annu Rev Biophys; 2024 Jul; 53(1):455-486. PubMed ID: 38382114 [TBL] [Abstract][Full Text] [Related]
32. Chronic Rhinosinusitis and Alzheimer's Disease-A Possible Role for the Nasal Microbiome in Causing Neurodegeneration in the Elderly. Harrass S; Yi C; Chen H Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681867 [TBL] [Abstract][Full Text] [Related]
33. Relationship of Wine Consumption with Alzheimer's Disease. Reale M; Costantini E; Jagarlapoodi S; Khan H; Belwal T; Cichelli A Nutrients; 2020 Jan; 12(1):. PubMed ID: 31941117 [TBL] [Abstract][Full Text] [Related]
34. Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A Palavicini JP; Wang C; Chen L; Hosang K; Wang J; Tomiyama T; Mori H; Han X Acta Neuropathol Commun; 2017 Jul; 5(1):56. PubMed ID: 28750656 [TBL] [Abstract][Full Text] [Related]
35. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging. Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773 [TBL] [Abstract][Full Text] [Related]
36. Amyloid structure exhibits polymorphism on multiple length scales in human brain tissue. Liu J; Costantino I; Venugopalan N; Fischetti RF; Hyman BT; Frosch MP; Gomez-Isla T; Makowski L Sci Rep; 2016 Sep; 6():33079. PubMed ID: 27629394 [TBL] [Abstract][Full Text] [Related]
37. RAGE Expression and ROS Generation in Neurons: Differentiation versus Damage. Piras S; Furfaro AL; Domenicotti C; Traverso N; Marinari UM; Pronzato MA; Nitti M Oxid Med Cell Longev; 2016; 2016():9348651. PubMed ID: 27313835 [TBL] [Abstract][Full Text] [Related]
38. Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease. Kulshreshtha A; Piplani P Neurol Sci; 2016 Sep; 37(9):1403-35. PubMed ID: 27250365 [TBL] [Abstract][Full Text] [Related]
39. BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease. Ghosh AK; Osswald HL Chem Soc Rev; 2014 Oct; 43(19):6765-813. PubMed ID: 24691405 [TBL] [Abstract][Full Text] [Related]
40. Placenta-derived mesenchymal stem cells improve memory dysfunction in an Aβ1-42-infused mouse model of Alzheimer's disease. Yun HM; Kim HS; Park KR; Shin JM; Kang AR; il Lee K; Song S; Kim YB; Han SB; Chung HM; Hong JT Cell Death Dis; 2013 Dec; 4(12):e958. PubMed ID: 24336078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]